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ABSTRACT 
 
 The use of nanomaterials for sensing and biological applications has recently 
gained interest owing to the unique physical, chemical and optical properties that arise 
when materials are reduced to the nanoscale. The unique optical properties exhibited by 
gold (Au) and silver (Ag) nanomaterials have made for versatile platforms in a wide 
range of applications including surface plasmon biosensing techniques and laser 
desorption/ionization mass spectrometry (LDI-MS). A primary driver for this work is the 
relative ease performing surface modifications to nanoparticles (NPs), which can be used 
to enhance the selectivity of ionization and/or facilitate analyte capture. The research 
presented here focuses on the development of AuNP and AgNP based biosensors for 
selective capture and ionization of low abundance compounds from complex mixtures 
and subsequent detection by LDI-MS and Matrix Assisted Laser Desorption Ionization-
Mass Spectrometry (MALDI-MS).  
 First, a ‘strategy’ for selective capture and ionization of specific compound 
classes based on chemical derivatization of gold nanorods (AuNRs) and infrared laser 
desorption ionization (IR-LDI) is described. LDI is performed at near infrared 
wavelengths (1064 nm) that overlap with the longitudinal surface plasmon resonance 
(LSPR) mode of AuNRs which allows absorbed energy from the laser to facilitate the 
desorption and ionization of the analyte. Capture of hydrophobic species using surfactant 
coated AuNRs and subsequent detection by IR-LDI-MS was also demonstrated in these 
experiments.  
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 Second, the fabrication of a label-free MS and optical detection based biosensor 
platform consisting of a phospholipid layer partially tethered to the surface of a gold 
nanorod for the detection of low abundance lipophilic analytes from complex mixtures is 
described. In these experiments, stable phospholipid capped AuNRs are produced by 
tethering some of the phospholipids to the surface of the AuNRs though a covalent, 
gold-thiol linkage. The effectiveness of the biosensor is demonstrated for the label-free 
detection of a membrane active lipophilic drug from aqueous solution and of a 
lipopeptide from fetal bovine serum. 
 Lastly, porous AgNP embedded thin films were fabricated by the sol-gel method 
and utilized as matrix-free LDI-MS biosensors applicable to several chemical classes. In 
these experiments, UV laser irradiation (337 nm) of the AgNP facilitates desorption and 
ionization of a number of peptides, triglycerides, and phospholipids. Preferential 
ionization of sterols from vesicles composed of olefinic phosphosphatidylcholines is also 
demonstrated.  
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NOMENCLATURE 
 
Au Gold 
Ag Silver 
NP(s) Nanoparticle(s) 
AgNP(s) Silver Nanoparticle(s) 
AuNP(s) Gold Nanoparticle(s) 
AuNR(s) Gold Nanorod(s) 
MS Mass Spectrometry  
LDI Laser Desorption Ionization 
MALDI Matrix Assisted Laser Desorption Ionization  
TEM Transmission Electron Microscopy 
FE-SEM Field Emission Scanning Electron Microscopy 
Uv-Vis Ultraviolet Visible Spectroscopy  
SPR Surface Plasmon Resonance 
LSPR Longitudinal Surface Plasmon Resonance 
m/z Mass to charge ratio 
CTAB Cetyltrimethylammonium Bromide 
SAM Self Assembled Monolayer 
AmB Amphotericin B 
XPS X-ray Photoelectron Spectroscopy 
TAG(s) Triacylglyceride(s) 
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DIOS Desorption Ionization On Porous Silicon 
CHCA α-Cyano-4-hydroxycinnamic acid 
DHB 2,5-dihydroxybenzoic acid 
DABA Diaminobenzoic acid 
DOPC 1-2,-dioleoyl-sn-glycero-3-phosphocholine 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
TEOS tetraethyl orthosilicate 
POPG 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol 
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1 
CHAPTER I 
 INTRODUCTION 
 
 Matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) has 
evolved as one of the most important “soft” ionization techniques for mass spectrometric 
analysis of polar, thermally labile molecules, especially peptides and proteins.1-4 In these 
experiments, first described by Karas and Hillenkamp, an organic matrix facilitates 
desorption and ionization of non-volatile biomolecules resulting in analyte ions with low 
internal energies and thus less fragmentation during analysis.2,5,6 A distinct analytical 
figure of merit associated with MALDI is its ability to ionize a broad range of compound 
classes present in chemical mixtures; however, there are cases where “ion suppression” 
limits the application of MALDI. Additionally, there are specific analyses where the 
general requirements of MALDI restrict its applications. Specifically, the matrix and 
analyte must (i) be miscible and (ii) must co-crystallize-, a process that is oftentimes 
achieved by trial and error.7 Uniform co-crystallization of the analyte and the matrix 
within the dried spot is also a concern given that uneven crystallization leads to the 
formation of “hot spots” in the matrix film yielding inconsistent spectral 
reproducibility.7,8  In addition, analysis of lower molecular weight compounds (<1000 
m/z) is often complicated by significant background noise in the form of matrix clusters, 
which congest the low mass region of the spectra.4,7 In an attempt to address some of 
these issues, alternative matrices for mass spectrometric analysis were investigated 
shortly after the initial description of the MALDI method. One of the most notable 
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methods was described by Tanaka et al. which employed cobalt nanoparticles suspended 
in glycerol to desorb and ionize large proteins and polymers up to mass-to-charge (m/z) 
of 100,000.9 Sunner, et al. went on to demonstrate the effectiveness of graphite particles 
(2-150 µm) suspended in glycerol to produce signal for a number of peptides and 
proteins by laser desorption ionization.10 The development of techniques stemming from 
MALDI has continued to progress and has evolved into the investigation of “matrix-
free” platforms for laser desorption ionization mass spectrometry (LDI-MS). Suizdak 
and coworkers introduced a matrix free method, desorption ionization on porous silicon 
(DIOS) which employs chemical etching of a silicon wafer for production of a porous 
surface which analytes are spotted directly on for signal production. Significant 
advantages of DIOS include, low sensitivity, minimized sample preparation, and 
applicability for the analysis of small molecules since the platform produces little to no 
background noise in the low m/z region.11-13 Derivatization of this porous silicon surface 
with a hydrophobic coating was also demonstrated to be useful for on-plate analyte 
enrichment of hydrophobic peptides.14,15  
 Recently, there has been a growing interest in the use of nanoparticles (NPs) and 
other novel “materials” as sensors for various classes of biomolecules. A primary driver 
for this work is the relative ease for performing surface modifications to NPs, which can 
be used to enhance the selectivity of ionization and/or facilitate analyte capture.  Such 
modifications generally have minimal impact on the unique optical and physical 
properties of the NPs that are so well-suited for a number of biosensing techniques, 
including LDI-MS.16-18 Recent applications utilizing gold (Au) and silver (Ag) NPs have 
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focused on monitoring shifts in the optical absorption spectra that occur upon changes in 
the local environment of the nanoparticles or for producing significant signal 
enhancements in Raman spectroscopy.19-23 Biofunctionalized plasmonic nanoparticles 
have also been used to target and destroy cancer cells by a photothermal process. In 
these experiments, the NPs absorb laser irradiation, which results in significant 
temperature rises and ultimately cell death by disruption of the plasma membrane of the 
diseased cell.24-29 It is this unique optical absorption and rapid temperature rise that 
makes NPs appealing for use as mass spectrometry platforms; as such properties could 
be exploited to desorb analytes coupled directly to the NP surface.  
 Several investigations in our lab have focused on the use of plasmonic NPs for a 
number of MS-based studies. Previously we showed that LDI ion yields from citrate-
capped AuNP varied with NP size, and subsequent experiments demonstrated that the 
presence of both anions and cations also influenced the laser induced ion signals.30,31 
Surface modification of AuNPs with a self-assembled monolayer of 4-aminothiophenol 
(4-ATP) also proved useful in increasing ion yields, reducing the number of alkali metal 
adducts, and extending the useful analyte mass range.18 By changing the composition of 
the NPs from Au to Ag, preferential ionization of olefins from mixtures was 
demonstrated owing to the unique coordination of Ag ions with double bonds of 
olefins.32 The studies described here outline a number experiments aimed at further 
developing the use of nanoparticle based methods for utilization as mass spectrometry 
platforms. Specifically, the investigation of gold nanorods (AuNRs) as energy absorbers 
of near infrared laser irradiation (1064 nm) for LDI-MS is discussed.16 Derivatization of 
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the AuNRs with stable lipid coatings for enrichment of membrane active and low 
abundance components in complex mixtures is also investigated.17 Development of a 
silver nanoparticle embedded thin film platform for matrix free analysis of a number of 
biological compounds is also discussed herein.  
 
Optical Absorption and Electronic Properties of Noble Metal Nanoparticles 
 The reduction of bulk noble metals to the nanoscale results in the emergence of 
unique physical, electronic and optical properties. For centuries, colloidal solutions of 
noble metal nanoparticles such as silver and gold have been used as colorants in glass 
and ceramic owing to the strong colors exhibited by the small metallic nanoparticles in 
solution. These colors are primarily caused by the surface plasmon resonances which 
result when coherent oscillations of the free electrons within the conduction band 
interact with an electromagnetic field. A schematic of this oscillation is demonstrated for 
a spherical nanoparticle in Figure 1, where the electric field from incoming light induces 
polarization of the free conduction electrons of the nanoparticle creating a charge 
separation between the free electrons and the ionic metal core. The electrons oscillate 
back and forth owing to a restoring Coloumbic force on the nanoparticle boundaries 
(surface) resulting in a dipole oscillation for a spherical nanoparticle in the simplest 
case.33,34  
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Figure 1. Schematic representation of polarized light interacting with a spherical gold 
nanoparticle and the resulting electron cloud displacement from the metallic core and 
subsequent oscillation.  
 
 
 
 Resonance of the frequency of the electromagnetic radiation with the electron 
motion results in a strong absorption band in the electromagnetic spectrum, which is 
around 520 nm in the case of spherical gold nanoparticles. In the case of gold nanorods, 
there are two directions along which polarization of the incident light can induce 
electron oscillation; the short and long axes of the nanorod, respectively. Excitation of 
the short axis, known as the transverse surface plasmon resonance, induces an oscillation 
similar to that of a spherical gold nanoparticle and gives rise to an absorption band 
around 520 nm which is not dependent on the aspect ratio of the nanorods. The aspect 
ratio is defined as the value of the long axis (length) divided by the short axis (width). 
Excitation along the long axis, known as longitudinal surface plasmon resonance, gives 
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rise to another lower energy absorption band which is dependent on the nanorod aspect 
ratio, and increases linearly to longer wavelengths with increasing aspect ratio. 
Schematics of the longitudinal and transverse surface plasmon resonances are 
demonstrated in Figure 2.  
 
 
 
Figure 2. Schematic representation of polarized light interacting with the long axis (left) 
and short axis (right) of a gold nanorod and the resulting electronic cloud displacement 
and oscillation from the metallic core. 
 
 
 
 The description of the origin of the optical properties for spherical metal 
nanoparticles was first theorized by Mie in 1908 when he solved Maxwell’s equations 
for the interaction of electromagnetic field with small spheres.33 In order to explain the 
optical properties of gold nanorods, an extension of Mie theory was necessary and is 
described by Gans theory, which treats the nanorods as ellipsoids and predicts the 
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longitudinal absorption band.35 Gans formula for randomly oriented ellipsoids in the 
dipole approximation follows:  
 
Where N represents the number of particles, V is the single particle volume, λ is the 
wavelength of light in a vacuum, εα is the dielectric constant of the surrounding medium, 
ε1 is the real and ε2 is the imaginary component of the refractive index of the 
nanoparticles. The geometrical factors of the ellipsoid are represented by Pj, and 
consider elongation along the three axes of the nanorod where A > B = C: 
 
 
Using these equations and a fixed value of 4 for the medium dielectric constant, it was 
determined that the maximum of the longitudinal band red-shifted 150 nm when the 
aspect ratio was increased from 2.6 to 3.6 and continued to increase linearly with 
increasing aspect ratio. The longitudinal band is also sensitive to the medium dielectric 
constant, and has been the focus of biosensing applications since changes in the local of 
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the environment of induce a shift of the SPR wavelength.36-38 Based on the tunability of 
the longitudinal band of gold nanorods to near IR wavelengths, we developed a method 
for utilization of gold nanorods as a mass spectrometry based platform.  
 
Time of Flight Mass Spectrometry 
 One of the most common types of mass analyzers for MALDI applications is the 
Time of Flight (TOF) mass spectrometer.39-41 In a typical TOF analysis, ions are first 
produced and accelerated by a potential difference U, between the sample plate and a 
grid or electrode to a given kinetic energy, KE. Thus, for an ion of a given charge state, 
z, and elementary charge, e:  
KE = zeU 
The ions, now with the same KE, then travel down a field free drift tube region where 
they will be separated based on their mass, m, due to their different velocities, v, based 
on the following equation:  
KE = ½ mv2, or v  
For a given flight time, t, and flight tube length, L: 
 
This equation can then be inverted to find the mass to charge ratio:  
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 One of the main sources of error involved in TOF instruments which can result in 
degrading the mass resolution, if not corrected, arises when ions of the same particular 
mass have different initial velocity distributions when extracted from the MALDI 
desorption plume.42 A method known as delayed extraction was developed in order to 
account for this difference in initial velocities. In this method, the electric field between 
the sample and the first electrode is initially kept field-free and after a short delay 
(nanoseconds) is triggered to extract the ions into the flight tube. During the initial field-
free delay time, ions traveling at a faster velocity will move closer to the first electrode 
than ions traveling at a slower velocity. Thus, when the electrode is turned on, the faster 
ions will experience less of a potential difference from the electric field and have less 
energy transferred to them than the slower ions. This results in the slower ions receiving 
more kinetic energy and eventually reaching the faster ions in the flight tube and 
eventually the detector.41,43-46 A schematic for a delayed extraction time of flight mass 
spectrometer is displayed in Figure 3.  
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Figure 3. Delayed extraction set up. Laser pulses (blue) ionize analytes and after a short 
time delay are pulsed into a field free flight tube.  
 
 
 
 Another method to compensate for the initial energy distribution of ions is the 
electrostatic ion reflector, also known as a reflectron, which was initially proposed by 
Mamyrin in 1973.47,48 The basic design of a reflectron time of flight instrument is shown 
in Figure 4.  
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Figure 4. Schematic of a basic reflectron time of flight mass spectrometry instrument, 
showing the ion path in reflector mode.  
 
 
 
 In these instruments, the reflector is a series of ring electrodes, which serve to 
create an electric field, intended to slow down ions and deflect them back towards a 
detector. A common analogy used to portray the mechanism by which a reflectron 
operates is to compare it to a ball rolling up a hill. For example, if two ions of the same 
m/z had different initial kinetic energy distributions, those ions with a higher initial 
kinetic energy will arrive at the reflectron at an earlier time than the slower ions with 
lower initial kinetic energy. The higher energy ions will “roll higher up the hill” or 
penetrate the reflectron more deeply than the lower energy ions, thus increasing the 
amount of time spent in the reflectron. Through tuning of the reflectron voltages the 
higher energy and low energy ions can be focused to reach the detector at the same time, 
improving the resolving power of the instrument. While reflectron time of flight mass 
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spectrometry can improve mass resolution, it is not without disadvantages; sensitivity 
and mass range are limited in these instruments.  
 
Sol-Gel Chemistry and Processing 
 The use of the sol-gel method for the production of materials has recently gained 
considerable interest owing to the versatility and simplicity of the method. As the name 
would imply, the sol-gel process is divided into two main components. In the most basic 
definition, a sol is a colloidal suspension of solid particles in a liquid and gelation is the 
process in which a free flowing solution is converted into a solid network; both of which 
are observed in some form during sol-gel processing. A typical sol-gel protocol for the 
production of materials is based on a series of reactions with a metal alkoxide precursor, 
which in the case of the experiments described in this dissertation, is strictly limited to 
the silicon based alkoxide, Tetraethyl orthosilicate (TEOS). In these experiments, by 
combining TEOS with 2-ethoxyethanol as a solvent, water to promote hydrolysis, and 
nitric acid as a catalyst, uniform colloidal particles comprising the sol, are formed by a 
series of hydrolysis and condensation reactions. Allowing the rate of condensation to 
continue promotes the eventual gelation of the sol, and the formation of a porous semi-
solid network of small cross-linked solid particles enclosing the liquid solvent. 
Generally, the point of gelation can be controlled by modifying reaction conditions such 
as pH and can be marked by an increase in viscosity and elasticity of the solution.49,50 As 
briefly mentioned before, there are two main reactions that occur for the formation of the 
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sol, hydrolysis and condensation of the TEOS precursor.51-54 The following reactions 
occur with TEOS for the formation of the silica network: 
Hydrolysis. 
 
 
Condensation. 
 Water forming condensation: 
 
 Alcohol forming condensation: 
 
 
 Hydrolysis in TEOS is significantly different from other metal based alkoxides, 
such as Zr and Ti, and requires for the addition of an acid or a base to catalyze the 
reaction. Whereas Zr(OCH2CH3)4 and Ti(OCH2CH3)4 carry a considerable partial 
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positive charge, ~0.65 and ~0.63, respectively; Si(OCH2CH3)4 carries a reduced partial 
positive charge of ~0.32. For Zr and Ti alkoxides, nucleophilic attack by the oxygen 
atom of water, which carries a partial negative charge, occurs relatively quickly for 
hydrolysis.54 TEOS, with its reduced partial charge on the Si atom hinders this 
nucleophilic attack, thus reducing the reaction kinetics and ultimately requiring an acid 
or a base catalyst for hydrolysis to occur in a moderate timeframe (minutes to hours). 
Although the final form of the hydrolyzed silica is greatly influenced by which type of 
catalyst is used, in these experiments, the sol-gel is processed solely by an acid based 
catalysis; hence the focus of this dissertation will be aimed towards discussion of the 
acid based catalysis of TEOS.  In acid catalyzed reactions, protonation of an oxygen 
atom on the alkoxide group occurs to withdraw the electron density around the Si atom 
making it more electrophilic, thus making the Si atom more susceptible to attack by 
water. As a result, the positive charge of the protonated alkoxide group is slightly 
reduced making the alcohol (ethanol) a better leaving group.53 The hydrolysis step in this 
system is a fast process and generally proceeds to completion before any significant 
amount of condensation occurs, making the condensation the rate-determining step. 
During condensation, a Si-O-Si network is formed and can follow two different 
mechanisms, (i) water forming condensation or (ii) alcohol forming condensation as 
demonstrated above. In water forming condensation, reaction occurs between two 
hydrolyzed TEOS molecules and a water molecule is formed as a result. The resulting 
water molecule can be used for further hydrolysis of another alkoxy group on a TEOS 
molecule, thus theoretically only a 2:1 mole ratio of water to TEOS are required for the 
 15 
 
complete hydrolysis and condensation. In alcohol forming condensation, reaction occurs 
between a hydrolyzed TEOS molecule and an unhydrolyzed molecule, resulting in the 
formation of an ethanol molecule. These reactions continue and eventually give rise to 
the final form the three-dimensional silica network. Generally, it has been found that in 
acid catalyzed reactions, the silica particles tend to from linear chains with a low 
crosslink density whereas under basic conditions, more branching and a higher crosslink 
density is observed. While the pH of the sol-gel solution can greatly influence the final 
form of the sol-gel reaction, other factors such as polarity of the solvent, reaction molar 
ratios, and temperature can also be used to manipulate the final structure. In these 
experiments, the addition of a silver nitrate is incorporated into the sol-gel reaction for 
the eventual production of a silver nanoparticle impregnated thin film. Although the 
exact mechanism for the incorporation of the silver ions into the silica network is 
relatively unknown, previous researchers have considered that the silver ions are 
involved in complexes with the network and are reduced thermally after heat treating. 
Additionally, the polarizability of the Ag+ ion has also been considered for the formation 
of a Si-O-Ag network produced by a cation exchange process with a hydrolyzed non-
bridging oxygen atom as follows: 
≡Si-OH + Ag+ → ≡Si-O-Ag + H+ 
The details of silver incorporation into the sol-gel system and characterization of the 
subsequent thin film are discussed in further detail in Chapter 4.55,56  
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CHAPTER II 
LONGITUDINAL SURFACE PLASMON RESONANCE BASED GOLD NANOROD 
BIOSENSORS FOR MASS SPECTROMETRY∗   
 
Introduction 
 Nanomaterials are of great interest because their behavior differs from that of 
both bulk materials and individual atoms or molecules. For example, the optical, 
chemical, and physical properties of nanomaterials are governed by size, composition, 
and their assembly into structures on the nano- and micro- scale. It is the unique 
chemical and optical properties that make nanomaterials attractive for a wide array of 
applications such as surface enhanced vibrations spectroscopies,57-61 targeted 
nanomedicines,25,62,63 and laser desorption ionization mass spectrometry (LDI-MS).64-75 
Additionally, nanomaterials offer several distinct advantages over traditional platforms 
for LDI-MS including; simplified sample preparation, relatively uncomplicated low 
mass spectra (less noise from matrix clusters), and greater flexibility in the sample 
deposition conditions (e.g., pH, solvents, etc.). We have recently reported on the use of 
size-selected AuNPs for UV LDI-MS analysis of biomolecules,31 functionalized AuNPs 
for increased analyte ionization efficiency as well as the useful analyte mass-to-charge 
(m/z) range,18 and AgNPs for the selective desorption/ionization of olefins.32 We have 
also published a detailed study exploring the effects of anions on analyte ion yields in 
                                                
∗ Reprinted with permission from Castellana, E. T.; Gamez, R. C.; Gomez, M. E.; Russell, D. H. 
Longitudinal Surface Plasmon Resonance Based Gold Nanorod Biosensors For Mass Spectrometry 
Langmuir 2010, 26, 6066. Copyright 2010 American Chemical Society.  
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LDI-MS from AuNPs.30 Here, the optical properties of AuNRs in designing a versatile 
biosensor platform capable of producing analyte ions under near-IR laser irradiation are 
exploited.   
 The optical properties of AuNRs are one aspect that makes them ideal candidates 
for the development of biosensing and nano-medicine platforms. Such applications often 
make use of the longitudinal surface plasmon resonance (LSPR) adsorption mode of 
AuNRs, for either optical detection20,21,76-78 or absorption-induced heating effects.26,63,79-
86 For nanomaterials, it is well established that the SPR absorption characteristics are 
highly dependent on particle size, shape, composition, and the dielectric constant of the 
surrounding medium.34 Illumination of NPs with electromagnetic radiation at or near the 
SPR absorption band has been demonstrated to cause elevated temperatures and changes 
in particle size.79,87,88 In fact, irradiation at the SPR wavelength has been used as a means 
of desorbing and ionizing metal atoms and clusters from the surface of thin metal films 
and other assemblies of nanomaterials.89-92 
 Recently, there have been several reports utilizing the SPR absorption of 
nanomaterials as a means to facilitate LDI of small molecules, peptides, polymers, and 
small proteins. These reports all focus on utilizing the SPR mode that occurs in the 
visible region of the electromagnetic spectra (~520 nm for Au). Visible SPR-LDI-MS 
has been demonstrated from thin metal films,93-95 AuNPs,96 Au-coated porous 
silicon,70,97 and AuNR arrays.70 Additionally, by mixing AuNPs with UV-absorbing 
organic matrices and irradiating sample spots at 532 nm, SPR induced MALDI-MS is 
possible.98 In the case of AuNRs, the absorption mode at ~520 nm is referred to as the 
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transverse SPR mode; however, AuNRs also exhibit a LSPR absorption band. The LSPR 
absorption maximum is dependent on the aspect ratio of the AuNRs and can vary from 
visible wavelengths well into the IR region.  
 The primary goal of the study reported here has been to investigate the 
effectiveness of AuNRs as a LSPR active mass spectrometry based biosensor. Herein 
two methods are presented. In the first, analyte is mixed with 4-aminothiophenol-capped 
AuNRs, spotted onto a stainless steel sample plate, and dried under vacuum prior to 
LSPR-LDI-MS analysis. By irradiating gold nanorods near their LSPR absorbance 
wavelength does facilitate the LSPR-LDI of surface adsorbed biomolecules. The second 
method utilizes the surfactant, Cetyltrimethylammonium bromide (CTAB), which coats 
the AuNR as a capping layer as a result of the synthesis of the nanomaterial. The CTAB-
capped AuNRs are incubated with an analyte capable of inserting itself into the CTAB 
layer surrounding the AuNRs. After centrifugal separation and rinsing, analytes 
adsorbed to the surface of the AuNRs are detected by irradiating the AuNRs near their 
LSPR absorbance wavelength. 
 
Materials and Methods 
 The CTAB used in this study was purchased from Alpha Asar, product #A15235, 
Lot 10123898. The peptide Angiotensin II was acquired from American Peptide 
Company, Inc. (Sunnyvale, CA).  All other chemicals used in this study were purchased 
from Sigma Aldrich, Inc. (St. Louis, MO), and all aqueous solutions were prepared using 
18.2 MΩ/cm2 water (NANOpure Ultrapure Water System, Barnstead, Dubuque, IA). To 
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synthesize the AuNRs, both a seed solution and a growth solution were prepared in 40 
mL dram vials. All glassware was cleaned with aqua regia, extensively rinsed, and baked 
at 150ºC for 2 hours prior to use. When working with aqua regia always wear protective 
clothing, goggles, gloves, lab coat and work in a clean well ventilated fume hood. The 
seed solution consisted of 5.0 mL of 0.00050 M chloroauric acid (HAuCl4) and 5.0 mL 
of 0.20 M CTAB. This solution was placed in a 27º C water bath and stirred at 1000 
rpm. The seed particles were formed by the rapid addition of 0.60 mL of ice-cold 0.010 
M sodium borohydride (NaBH4). The resulting seed solution was stirred for 2 minutes 
and allowed to age for an additional 10 minutes prior to use. The growth solution was 
made by mixing: 25 µL of 0.040 M silver nitrate (AgNO3), 5.0 mL of 0.20 M CTAB, 20 
µL of 0.5 M sulfuric acid (H2SO4), 5.0 mL of 0.0010 M HAuCl4, and 70 µL of 0.0788 M 
ascorbic acid. The resulting growth solution was gently mixed until the color changed 
from dark yellow to colorless. A 12 µL aliquot of the seed solution was added; the 
solution was gently mixed again, and incubated at 27º C. The final growth solution was 
aged for a minimum of 2 hours. During this time the color of the solution changed from 
clear to light peach. The AuNRs were characterized by Transmission Electron 
Microscopy (TEM) and UV-Vis spectroscopy.  
 For preparation of 4-aminothiophenol (4-ATP) functionalized AuNRs, a surface 
exchange protocol was developed. After synthesis of the AuNRs, excess CTAB was 
removed from 5.0 mL of the as prepared solution by two cycles of centrifugation at 4500 
g for 30 minutes, removal of the supernatant and subsequent resuspension of the AuNRs. 
After the first centrifugation, the AuNRs were resuspended in 5.0 mL of water and after 
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the second centrifugation the AuNRs were resuspended in 5.0 mL of a 10 mM 4-ATP 
solution containing 0.1% trifluoroacetic acid (TFA). The resulting solution was 
sonicated at 50ºC for 30 minutes (VWR, bath sonicator, model B3500A-DTH). The 
AuNR/4-ATP mixture was then centrifuged at 4500 g, resuspended in 5.0 mL of 10 mM 
4-ATP in 0.1% TFA and sonicated again at 50º C for 30 minutes. The excess 4-ATP and 
remaining CTAB was removed from the AuNR solution by two cycles of centrifugation 
at 4500 g.  The final 4-ATP capped AuNR solution was prepared by removal of the 
supernatant, and resuspension in 2.5 mL of 0.1% TFA.  
 Exchange of CTAB with mPEG-thiol followed a similar exchange protocol as 4-
ATP. Excess CTAB was removed from 5.0 mL of the as prepared AuNR solution by two 
cycles of centrifugation at 4500 g for 30 minutes, removal of the supernatant and 
subsequent resuspension of the AuNRs. After the first centrifugation, the AuNRs were 
resuspended in 5.0 mL of water and after the second centrifugation the AuNRs were 
resuspended in 5.0 mL of a 10 mM mPEG-thiol solution. The resulting solution was 
sonicated at 50ºC for 30 minutes (VWR, bath sonicator, model B3500A-DTH). The 
AuNR/mPEG-thiol mixture was then centrifuged at 4500 g, resuspended in 5.0 mL of 10 
mM mPEG-thiol and sonicated again at 50º C for 30 minutes. The excess mPEG-thiol 
and remaining CTAB was removed from the AuNR solution by two cycles of 
centrifugation at 4500 g.  The final mPEG-thiol capped AuNR solution was prepared by 
removal of the supernatant, and resuspension in 2.5 mL of 10mM mPEG-thiol solution. 
 The AuNRs were characterized by Transmission Electron Microscopy (TEM) 
and UV-Vis spectroscopy. All TEM images were obtained using a JEOL JEM-2010 
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TEM (Tokyo, Japan). Mass spectrometry data was acquired with a Voyager DE-STR 
MALDI-TOF-MS (Applied Biosystems, Foster City, CA). LSPR-LDI-MS was obtained 
using a Nd:YAG laser (1064 nm, Tempest-20, New Wave Research, Fremont, CA). UV 
LDI-MS (337 nm) was obtained using a nitrogen laser (model VSL-337ND-S, Thermo 
Laser Science, Franklin, MA). The laser energy was measured using a thermopile 
detector (model PS-310WB, Gentec Electro-Optics, Quebec, QC, Canada), a 200 Ohm 
DB-15 BNC adaptor (Gentec Electro-Optics), and a multimeter (model 8840A, Fluke, 
Everett, WA).  
 To demonstrate the use of AuNRs for the LSPR-LDI-MS of biologically relevant 
analytes, 4-ATP- or CTAB-capped AuNRs were mixed with the peptide Angiotensin II 
in ~1:500 molar ratio, and 2.0 µL aliquots of the mixture were spotted directly onto a 
stainless steel sample plate and dried under vacuum. LSPR-LDI-MS was carried out by 
irradiating the sample spot with 5-30 µJ/pulse of 1064 nm laser light. 
 
Results and Discussion 
 We hypothesized that for a given AuNR aspect ratio, analytes adsorbed on the 
surface of the rods can be desorbed and ionized (e.g., proton capture, proton loss) under 
irradiation corresponding to the nanorods LSPR absorption wavelength. AuNRs are 
prepared using a modified version of the surfactant directed seed-mediated growth 
process.99,100 Using this method, it is possible to synthesize AuNRs with a variety of 
aspect ratios simply by varying the reaction conditions (i.e., ratios of Au, Ag, or CTAB). 
The λmax of the LSPR absorption in the AuNRs is directly proportional to the aspect ratio 
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of the AuNRs. By growing AuNRs to an aspect ratio of ~5:1 and replacing the CTAB 
with a self assembled monolayer (SAM), we were able to increase the wavelength of the 
LSPR absorption mode of the AuNRs so that they would absorb the 1064 nm emission 
of a Nd:YAG laser when dried in a sample spot. Figure 5 contains UV-vis and TEM 
data of the AuNRs before and after replacing the CTAB with 4-ATP. 
 To demonstrate the use of gold nanorods for the LSPR-LDI-MS of biologically 
relevant analytes, 4-ATP- or CTAB-capped AuNRs were mixed with the peptide 
Angiotensin II in ~1:500 molar ratio, and 2.0 µL aliquots of the mixture were spotted 
directly onto a stainless steel sample plate and dried under vacuum. LSPR-LDI-MS was 
carried out by irradiating the sample spot with 5-30 µJ/pulse of 1064 nm laser light 
(Figure 6). The laser beam was focused to a diameter of ~50 µm with an average laser 
energy of ~15 µJ/pulse; thus, the resulting laser fluence was estimated to be ~0.76 J/cm2. 
From these values we estimate a rapid rise in AuNR temperature of at least several 
hundred degrees. Because the volume of the AuNRs will remain almost constant, this 
energy will be channeled internally into the reshaping and fragmentation of the AuNRs 
and externally into the LDI of analytes present at the surface of the AuNRs.79,101,102 The 
LSPR-LDI mass spectra of the peptide Angiotensin II acquired using AuNRs and 1064 
nm laser irradiation are shown in Figure 7. 
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Figure 5. Absorbance spectra of (a) CTAB-capped AuNRs (blue) and 4-ATP-capped 
AuNRs (red) and TEM images of (b) CTAB-capped AuNRs and (c) 4-ATP-capped 
AuNRs. 
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Figure 6. A schematic representation illustrating the use of AuNRs for LSPR-LDI-MS 
utilizing infrared laser irradiation. (a) Analyte is mixed with AuNRs in solution, spotted 
onto the sample plate, and dried prior to analysis. (b) Ions are produced by 1064 nm 
irradiation of a sample spot containing a mixture of AuNRs and analyte. 
 
 25 
 
 
Figure 7. LSPR-LDI mass spectra of Angiotensin II (m/z = 1046.5) using 4-ATP capped 
AuNRs (dark blue), 4-ATP capped AuNPs (green), and CTAB-capped AuNRs (light 
blue). 
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Figure 8. LSPR-LDI mass spectra of [Maltohexaose + Na]+ (m/z = 1013.3) using 4-ATP 
capped AuNRs.  
 
 
 
 Note that peptide ions are only observed when the CTAB is replaced with a SAM 
of 4-ATP. Analyte ions are not observed from sample spots containing mixtures of 4-
ATP-capped AuNP (no LSPR absorption) and peptide or from CTAB coated AuNRs 
(Figure 7). Similar results are observed for the oligosaccharide maltohexaose (Figure 
8). The presence of CTAB on the surface of the nanorods can inhibit desorption and 
ionization of analyte by numerous mechanisms. We speculate that (i) the CTAB does not 
provide a sufficient proton source to ionize the peptide and (ii) the positively charged 
CTAB bilayer inhibits the peptide from adsorbing to the AuNR surface. Decoupling the 
peptide from the AuNR surface diminishes energy transfer from the AuNRs to the 
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peptide during the LDI event. In support of this argument note that previous work has 
demonstrated that when in solution the CTAB bilayer on the surface of AuNRs is a good 
thermal insulator relative to biopolymers.103 If the thermal energy generated by the 
relaxation of the surface plasmons is confined to the AuNRs rather then being consumed 
by the process of analyte desorption and ionization, then we would expect to produce 
more gold cluster ions and less analyte ions during the LDI event. This result is readily 
observed in the mass spectrum (Figure 7, light blue trace) of CTAB capped AuNRs as 
[Au3]+ and [Au5]+ ions are the dominant signals. Additionally, cetyltrimethylammonium 
ions [CTA]+ are observed in the low mass region of the spectrum of CTAB capped 
AuNRs, presumably because the [CTA]+ exists as a preformed ion and is in direct 
contact with the surface of the AuNRs.  We hypothesize that the laser energy being 
absorbed by the surface plasmons is transferred from the AuNRs to their surroundings is 
used for desorption of [CTA]+ ions rather then the production and desorption of analyte 
ions. 
 The presence of a 4-ATP monolayer has the opposite effect. Under the mildly 
acidic conditions employed, the 4-ATP monolayer will be partially protonated. This 
allows the peptide to interact with the surface of the monolayer through hydrogen 
bonding and also provides a proton source to facilitate peptide ionization. We suspect 
that the shared proton can easily be transferred to the peptide during laser irradiation 
enhancing the peptide ion yield in this experiment. Since the peptide is adsorbed in close 
proximity to the AuNR surface, there will be sufficient energy transfer from the AuNRs 
to the peptide/4-ATP complex for desorption and ionization to occur. As shown in 
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Figure 7 (dark blue trace), abundant protonated peptide ions are observed, whereas gold 
cluster ions are not observed. This indicates that the 4-ATP monolayer allows energy 
transfer to the peptide rather than the formation of gold cluster ions. In the case of the 
spherical gold nanoparticles capped with 4-ATP, we would expect similar analyte-
surface interactions and a sufficient proton source, however the spherical nanoparticles 
do not absorb at 1064 nm; thus, peptide ion signal is not observed (Figure 7, green 
trace). It is apparent from the data shown in Figure 7 that analytes can be desorbed and 
ionized using the LSPR absorption of gold nanorods when (i) there is sufficient optical 
absorption of the laser energy, (ii) the analyte is present at or very close to the surface of 
the AuNR, and (iii) sufficient energy is transferred from the AuNRs to the analyte, 
resulting in desorption and ionization. 
 Despite the fact that the CTAB bilayer surrounding the AuNRs inhibits the 
production of analyte ions in LSPR-LDI-MS, we set out to make use of the amphoteric 
nature of the surfactant. Previous studies have shown that hydrophobic molecules will 
partition into the CTAB bilayer surrounding AuNRs. On the basis of these experiments, 
we hypothesized that it should be possible to capture a hydrophobic analyte within the 
CTAB bilayer and subsequently detect it by LSPR-LDI-MS. To test our hypothesis, we 
demonstrate the capture of benzyldimethylhexadecylammonium chloride (BDAC). In 
the first, 1.0 mL of CTAB-capped AuNRs was centrifuged at 4500g and resuspended in 
300 µL of water twice. A 100 µL aliquot of the twice resuspended AuNR solution was 
incubated in 1.0 mL of 5 µM BDAC for 30 minutes. Following incubation, the AuNRs 
were separated from the BDAC solution by centrifugation at 4500g, removal of the 
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supernatant, and resuspension in 1 mL of water. After a second centrifugation (4500g) 
and supernatant removal, the AuNRs were resuspended in 60 µL of water. A 1.0 µL 
aliquot of this solution was spotted onto a sample plate and dried under vacuum. 
Analysis reveals the successful capture of BDAC in the CTAB bilayer surrounding the 
nanorods and subsequent detection by LSPR-LDI-MS (Figure 9). Control experiments 
attempting to capture BDAC with mPEG-capped AuNRs produced no discernible 
[BDA]+ signals above the background (Figure 10) owing to the minimization of 
hydrophobic interactions between the AuNR surface and the target analyte.  
 
 
 
Figure 9. LSPR-LDI mass spectrum of benzyldimethylhexadecylammonium ion [BDA]+ 
(m/z = 360.36) captured in the CTAB bilayer capping of the AuNRs. The peak labeled 
with an asterisk corresponds to a [CTA]+ fragment ion. 
 30 
 
 
Figure 10. LSPR-LDI mass spectrum of an attempt to capture [BDA]+ utilizing mPEG-
thiol functionalized AuNR. Note: There is no signal at m/z = 360.36 corresponding to the 
[BDA]+ owing to the absence of hydrophobic interaction between the target analyte and 
AuNR surface. [CTA]+ exists as residual coating, however, its presence is not sufficient 
enough to warrant analyte capture.  
 
 
 
Conclusions 
 The first examples of laser desorption/ionization of biomolecules using AuNRs 
irradiated with 1064 nm laser pulses are demonstrated. The laser energy deposited via 
the LSPR mode of the AuNRs is then used to desorb and ionize the analyte. LDI of 
synthesized AuNRs yields ions exclusively from the CTAB capping agent used in the 
NR synthesis thus, the CTAB must be replaced with a SAM in order for this method to 
produce detectable amounts of analyte ions. Because the analyte does not readily desorb 
and ionize without the use of an organic or nanomaterial matrix, even at 337 nm, we 
 31 
 
conclude that the SAM is necessary to facilitate the LDI process for non “preformed” 
ion analytes. The SAM helps to facilitate LDI by assisting in the transfer of a proton to 
the analyte and/or sequestering the analyte in close proximity of the AuNR surface. 
Conversely, the CTAB capping agent has little or no ability to transfer a proton and may 
insulate the analyte from the energy transfer process from the AuNRs during LDI. We 
are currently designing experiments to further investigate our model for analyte LDI 
from the surface of AuNRs and nanomaterials in general. 
 The utility of AuNRs as an analyte capture platform is also investigated. Making 
use of the readily prepared nanorods, we have demonstrated the capture of an analyte 
that exists as a “preformed ion” and has an affinity for the CTAB on the surface of the 
nanorods. The analyte BDAC was sequestered and concentrated by the CTAB-capped 
AuNRs and subsequently detected by LSPR-LDI-MS. Conversely, AuNRs that were 
functionalized with a SAM of mPEG thiol exhibited no capture capabilities. These 
experiments demonstrate the feasibility of tailoring the surface chemistry of the AuNR 
platform to afford analyte capture and MS detection from complex samples. This 
strategy has potential for applications in biomarker screening to capture and identify 
unknown analytes present in low abundances from complex biological fluids. 
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CHAPTER III 
LABEL-FREE BIOSENSING WITH LIPID FUNCTIONALIZED GOLD 
NANORODS∗ 
 
Introduction 
 Nanomaterials offer versatile platforms for development of analyte capture and 
bioanalytical sensor platforms owing to their unique optical and physical properties.104-
107 Additionally, the high surface area combined with the capacity to precisely control 
the surface chemistry gives nanomaterials an inherent advantage when employed in 
capture or separation techniques. Identification of lipophilic analytes is important in a 
wide range of fields including: pharmacokinetics,108 food safety,109 lipidomics,110,111 and 
biomarker screening.112,113 Therefore, a biosensor platform capable of selectively 
targeting lipophilic analytes from complex solutions for rapid detection would be widely 
applicable. Gold nanorods (AuNRs) have rapidly become powerful base platforms for 
development of optical biosensors,37,112,114-116 nanomedicines,26,117 and gene delivery.118-
120 In previous work we demonstrated the unique capabilities of AuNRs for the infrared 
laser desorption/ionization (IR-LDI-MS) of various biomolecules for MS analysis.16 
Recently, several reports have focused on the combination of lipids and nanomaterials 
for a handful of bioanalytical applications. To date there are limited numbers of methods 
for producing lipid capped AuNRs.118,121-123 The general procedure involves replacing 
                                                
∗ Reprinted with permission from Castellana, E. T.; Gamez, R. C.; Russell, D. H. Label-Free Biosensing 
with Lipid-Functionalized Gold Nanorods. Journal of the American Chemical Society 2011, 133, 4182. 
Copyright 2011 American Chemical Society. 
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the cationic surfactant cetrimonium bromide (CTAB), which is necessary to grow the 
AuNRs, with lipids. The majority of these methods rely on the interaction of the 
quaternary amine of phosphatidylcholine headgroup, which is similar to CTAB, with the 
surface of the AuNRs. This weak interaction allows for a lipid bilayer to form around the 
AuNR through a self-assembly process.121 However, for utility in our experiments, the 
weak interaction of the chemisorbed lipids is not strong enough to form a stable lipid 
bilayer that can withstand multiple cycles of centrifugation. That is, once excess lipid is 
removed from solution the lipid capped AuNRs begin to aggregate; a trend that also 
occurs when excess CTAB is removed from solution of CTAB capped AuNRs. To 
circumvent this problem, we have developed a method of producing stable lipid capped 
AuNRs by tethering some of the lipids to the AuNR through a thiol gold linkage. Here, 
we report a label-free mass spectrometry (MS) based biosensor platform for the 
detection of low abundance lipophilic analytes from complex mixtures. 
 
Materials and Methods 
 The CTAB used in this study was purchased from Alpha Asar, product #A15235, 
Lot #10123898. Chloroauric acid, sodium borohydride, ascorbic acid, and silver nitrate 
were purchased from Sigma Aldrich, Inc. (USA), and all aqueous solutions were made 
using 18.2 MΩ/cm2 water (NANOpure Ultrapure Water System, Barnstead, Dubuque, 
IA). 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoglycerol (POPG) and 1,2-Dipalmitoyl-sn-Glycero-3-
Phosphothioethanol (DPPTE) in chloroform were purchased from Avanti Polar Lipids. 
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Lipopeptide (Myristoyl-Lys-Arg-Thr-Leu-Arg) was purchased from American Peptide 
Co., Inc. (Sunnyvale, CA) and fetal bovine serum was purchased from Sigma Aldrich, 
Inc. (USA). 
 To synthesize the AuNRs, both a seed solution and a growth solution were 
prepared in 40 mL dram vials. All glassware was cleaned with aqua regia, extensively 
rinsed, and baked at 150ºC for 2 hours prior to use. When working with aqua regia 
always wear protective clothing, goggles, gloves, lab coat and work in a clean well 
ventilated fume hood. The seed solution consisted of 5.0 mL of 0.00050 M Chloroauric 
acid (HAuCl4) and 5.0 mL of 0.20 M CTAB. This solution was placed in a 27º C water 
bath and stirred at 1000 rpm. The seed particles were formed by the rapid addition of 
0.60 mL of ice-cold 0.010 M sodium borohydride (NaBH4). The resulting seed solution 
was stirred for 2 minutes and allowed to age for an additional 10 minutes prior to use. 
The growth solution was made by mixing: 25 µL of 0.040 M silver nitrate (AgNO3), 5.0 
mL of 0.20 M CTAB, 20 µL of 0.5 M sulfuric acid (H2SO4), 5.0 mL of 0.0010 M 
HAuCl4, and 70 µL of 0.0788 M ascorbic acid. The resulting growth solution was gently 
mixed until the color changed from dark yellow to colorless. A 12 µL aliquot of the seed 
solution was added; the solution was gently mixed again, and incubated at 27º C. The 
final growth solution was aged for a minimum of 2 hours. During this time the color of 
the solution changed from clear to light peach. The AuNRs were characterized by 
Transmission Electron Microscopy (TEM) and UV-Vis spectroscopy. 
 To prepare the vesicles, appropriate amounts of lipids (3.07x10-5 mol DPPC and 
3.42x10-6 mol DPPTE) or (2.92 07x10-6 mol POPG and 3.42x10-6 mol DPPTE) were 
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mixed, dried under a stream of nitrogen, and desiccated under vacuum for ~3 hours. 
After desiccation, lipids were rehydrated in 5.0 mL of water and sonicated for ~20 
minutes to ensure the lipids were fully dissolved. The solution was then subjected to 10 
freeze thaw cycles by alternating between immersions in liquid nitrogen followed by 
immersion in a 25ºC water bath. Next, the lipid solution was extruded 10 times through 
100 nm polycarbonate pore size filters. 
 After synthesis of the gold nanorods, excess CTAB was removed from 10 mL of 
the as prepared solution by two cycles of centrifugation at 4500 g for 20 minutes, 
removal of the supernatant and subsequent resuspension of the nanorods.  Following the 
first centrifugation, the nanorods were resuspended in 5.0 mL of a 10-fold dilution of the 
lipid vesicle preparation. After a second centrifugation and resuspension in an additional 
5.0 mL of a 10-fold dilution of the lipid vesicles, the resulting solution was sonicated at 
50º C for 30 minutes (VWR, bath sonicator, model B3500A-DTH).  The lipid nanorod 
mixture was then centrifuged at 4500 g for 20 minutes, resuspended in 5.0 mL of 10-fold 
dilution of lipid vesicles and sonicated again at 50º C for 70 minutes.  This lipid nanorod 
mixture was then allowed to cool to room temperature then stored at 4º C. 
 For the capture experiment, 1.0 mL of the prepared lipid nanorods was used. The 
excess lipid vesicles were removed from the nanorod solution by two cycles of 
centrifugation at 3000 g, removal of the supernatant and resuspension in water. After the 
second cycle of centrifugation, the solution was concentrated to 200 µL. A 100 µL 
aliquot of the twice-centrifuged lipid nanorod solution was incubated with 500 µL of a 
1.0 µM Amphotericin B (AmB) solution for 30 minutes at room temperature. Following 
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incubation, the nanorods were separated from the AmB solution by centrifugation at 
3000 g, removal of the supernatant and resuspension in 600 µL of water. After a second 
centrifugation (3000 g), and removal of the supernatant, the nanorods were resuspended 
in 40 µL of water. This capture solution was mixed with 2,5-dihydroxybenzoic acid 
(DHB), and a 1.0 mg/mL sodium chloride (NaCl) solution, in a 4:2:1 ratio, respectively. 
A 1.0 µL aliquot was spotted onto the sample plate and dried under vacuum for MS 
analysis. MALDI-MS was acquired at laser fluence just above the threshold required for 
desorption-ionization. 
 For capture of a target lipopeptide from a complex mixture, fetal bovine serum, 
lipid capped nanorods were prepared for the capture experiment in an identical method 
as previously stated. A 100 µL aliquot of the twice-centrifuged nanorod solution was 
incubated with 500 µL of an 11 nM lipopeptide in a 3.0 mg/mL fetal bovine serum 
solution for 20 minutes at room temperature. Following incubation, the nanorods were 
separated from the serum solution by centrifugation at 3000 g, removal of the 
supernatant and resuspension in 600 µL of water. After a second centrifugation (3000 g), 
and removal of the supernatant, the nanorods were resuspended in 40 µL of water. For 
MALDI analysis, a 1.0 µL aliquot of the capture solution containing the lipid capped 
AuNRs was spotted onto a stainless steel MALDI plate and dried under vacuum. This 
process was repeated until a total of 5.0 µL was deposited in the same spot. Finally, 1.0 
µL of α-Cyano-4-hydroxycinnamic acid (CHCA) was spotted over the dried sample spot 
and MALDI-MS data was acquired. MALDI-MS was acquired at laser fluence just 
above the threshold required for desorption-ionization. 
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Results and Discussion 
 The lipid capped AuNRs were characterized by UV-visible spectroscopy (Figure 
11), MALDI-MS (Figure 12), and transmission electron microscopy (Figure 13). 
Analysis of TEM images provides evidence that the lipid capping layer protects the 
AuNRs during production of the biosensor and after multiple cycles of centrifugation 
and resuspension. TEM images also reveal that the lipids protect the integrity of the 
AuNRs and prevent aggregation during deployment in analyte capture experiments. 
Additionally, the longitudinal surface plasmon resonance peak (~850 nm) and the 
MALDI mass spectra of the lipid capped AuNRs remains unchanged after several cycles 
of centrifugation and resuspension (Figure 14). This suggests that the tethered lipid 
capping is both stable and provides ample protection of the AuNRs against aggregation 
during processing.  
 
 
 
Figure 11. UV-vis spectra of CTAB capped AuNRs (blue) and lipid capped AuNRs 
(red). 
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Figure 12. MALDI mass spectrum of lipid capped AuNRs before employment as affinity 
probes for capture experimental. 
 
 
 
 
Figure 13. TEM images of (a) CTAB functionalized AuNRs and (b) lipid functionalized 
AuNRs. 
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Figure 14. UV-vis spectra after multiple cycles of centrifugation and resuspension of the 
lipid capped AuNRs in water.  Note: each data set is normalized to 1.0 and offset by 0.1 
on the y-axis for clarity. 
 
 
 
 Many drugs function through interactions with cellular membranes. These 
interactions include processes such as targeting cell surface receptors,124,125 disrupting 
cell membranes,126-128 and traversing the cell membrane. Amphotericin B (AmB), an 
antifungal drug, whose mechanism of action involves formation of pores by inserting 
into and disrupting cellular membranes, makes it an ideal candidate to demonstrate 
capture of cell membrane active drugs in the lipid capped AuNRs. Additionally, AmB 
exhibits optical absorption in the UV-visible region owing to its highly conjugated 
structure, thus allowing optical confirmation of its capture by the lipid capped AuNRs.  
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Capture experiments were performed by incubating lipid capped AuNRs in 0.5 mL of an 
aqueous 1.0 µM AmB solution for 20 minutes. Following incubation, the AmB-lipid 
capped AuNR complex was separated from the solution by centrifugation, washed twice 
with water and resuspended. The final AmB-lipid capped AuNR complex was 
concentrated to 40 µL prior to analysis by MALDI-MS and an aliquot was re-diluted for 
UV-vis spectroscopy. Figure 15 contains the optical absorption spectra of the lipid 
capped AuNRs (red trace), a 10 µM AmB solution (green trace), and of the AmB lipid 
capped AuNR complex (blue trace) spectra. Successful capture of the AmB by the lipid 
capped AuNRs is confirmed by the presence of AmB’s optical signature observed in the 
300-500 nm region of the absorption spectrum. Owing to the sensitivity of the SPR band 
to the dielectric constant of the surrounding medium, the local environment change 
resulting from the insertion of the AmB into the lipid coating of the AuNRs induces a 
perturbation in the longitudinal surface plasmon resonance band of the capture 
experiment which is also observed in the absorption spectrum. 
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Figure 15. UV-vis spectra of the lipid capped AuNRs (red), a 10 µM solution of AmB  
(green) and lipid capped AuNRs after capture of AmB from solution (dark blue). 
Distinct UV-vis spectra are observed for both the lipid capped AuNRs, and the AmB. In 
the procedure where the AmB is captured by the AuNRs, a combination of each of the 
individual spectra is observed. 
 
 
  
 The concentrated AmB-lipid capped AuNR complex was mixed with the organic 
matrix 2,5-dihydroxybenzoic acid (DHB) prior to MALDI-MS analysis.  As a control, a 
mixture of the capture solution (1.0 µM AmB) and lipid capped AuNRs was mixed 
together with DHB without incubation or centrifugation.  By MALDI-MS, we are only 
able to observe the AmB following its capture and concentration by the lipid capped 
AuNRs (Figure 16). No AmB signal is observed from the control experiment (Figure 
17).  Also observed in both mass spectra (Figures 16 and 17) are peaks corresponding 
to the lipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), a DPPC dimer, and a 
complex between a DPPC molecule and a CTAB molecule. It is also important to note 
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that AmB was not detected by direct MALDI-MS analysis of the 1.0 µM AmB capture 
solution (Figure 18). 
 
 
 
Figure 16. MALDI mass spectrum of AmB-AuNR complex after AmB was captured 
from an aqueous 1.0 µM AmB solution. The peak labeled with an asterisk (*) was 
identified as a CTAB-DPPC complex by MS/MS. 
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Figure 17. MALDI mass spectrum of control experiment which includes a mixture of 
AmB and lipid capped AuNRs without incubation. This demonstrates that the presence 
of the lipid capped AuNRs alone is not enough to facilitate interaction and that the 
incubation period is necessary for partition of AmB into the bilayer surrounding the 
AuNRs. The peak labeled with an asterisk (*) was identified as a CTAB-DPPC complex 
by MS/MS. 
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Figure 18. MALDI mass spectrum of a 1.0 µM AmB capture solution. Signal for the 
analyte is not observed before enrichment by the lipid capped AuNRs. 
 
 
  
 Modification of the lipid vesicles to incorporate a negatively charged headgroup 
was also investigated and proved equally as successful for the capture of low abundance 
analytes from aqueous solutions. By changing the bulk composition of the lipid vesicles 
from the phosphatidylcholine, DPPC, to a phosphatidylglycerol, POPG, the AuNRs were 
able to be successfully functionalized with the POPG. An identical capture experiment 
as outlined above was employed for the capture of Valinomycin and Melittin from dilute 
aqueous solutions. Valinomycin, a cyclic peptide and potassium specific ionophore used 
to transport metal ions across lipid membranes contains a hydrophobic region allowing 
for it to partition into lipid bilayers126. Figure 19 demonstrates the analysis of a dilute 
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solution (100 nM) of Valinomycin, which did result in signal for the analyte, however, it 
was buried in the background noise and an isotopic distribution for the analyte was 
barely discernable. After a capture experiment from a 500 µl aliquot of a 100 nM 
solution using the POPG functionalized AuNRs, analyte signal corresponding to 
[M+Na]+ was readily observable for Valinomycin (Figure 20). An additional analyte 
which has been extensively studied and is known to interact and associate with lipid 
bilayers, Melittin, a 26 amino acid residue peptide was also demonstrated to be 
successfully enriched after employing the POPG functionalized AuNRs. Similar to the 
previous analytes, MALDI-MS of the melittin solution (100nM) gives rise to no signal 
for the target analyte (Figure 21) and it is only after enrichment utilizing the POPG 
functionalized AuNRs that signal is obtained at m/z = 2846.4 corresponding to [M+H]+ 
for the analyte. Figure 22 demonstrates the resulting spectrum after enrichment in which 
the inset contains the mass range corresponding to the analyte signal; revealing a clearly 
resolved isotopic distribution and a good signal to noise against the background.  
 
 
 
 
Figure 19. MALDI mass spectrum of a 100 nM Valinomycin solution. The analyte 
signal is present, however, prevalent background noise complicates the spectrum. 
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Figure 20. MALDI mass spectrum of the capture experiment from a 100 nM 
Valinomycin solution utilizing POPG functionalized AuNRs. The inset contains the 
mass range corresponding to the analyte signal, demonstrating the reduced background 
signal and improvement in signal-to-noise.  
 
 
 
 
Figure 21. MALDI mass spectrum of a 100 nM Melittin solution which gave rise to no 
discernable analyte signal.  
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Figure 22. MALDI mass spectrum of the capture experiment from a 100 nM Melittin 
solution utilizing POPG functionalized AuNRs. The inset contains the mass range 
corresponding to the analyte signal, demonstrating the reduced background signal and 
improvement in signal-to-noise. 
 
 
 
 These results demonstrate, for the first time, the successful application of a 
hybrid lipid capped AuNR biosensor for the capture and label-free detection of a 
membrane active drug by MS. Although the unique optical absorption of AmB would be 
sufficient to detect its presence, many analytes will not elicit such an obvious change in 
the absorbance profile.  In fact, if the analyte does not strongly absorb in the ultraviolet 
or visible region of the electromagnetic spectrum, then only a small change in the 
absorbance profile of the lipid capped AuNRs would be observed. On the other hand, if 
multiple species are present, any change observed in the optical spectra could not be 
confidently assigned to an individual analyte. Ultimately, for the analysis of complex 
samples, where it is desired to capture multiple analytes simultaneously and/or identify 
unknown analytes, MALDI-MS is one of the best detection methods available.  This is 
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particularly important in the development of point-of-care molecular diagnostic assays 
where multiplexed high throughput analysis of body fluids is the key to success.129  
 The applicability of the lipid capped AuNR as a label-free biosensing platform, 
was tested by capturing a lipophilic analyte present at low concentration (11 nM) from a 
complex biological matrix, fetal bovine serum. To prepare the mixture, a stock solution 
of the target lipopeptide was diluted to a final concentration of 11 nM in 3.0 mg/mL fetal 
bovine serum. Capture of the lipopeptide, myristoyl-Lys-Arg-Thr-Leu-Arg, was 
performed using a similar method as outlined above for the AmB capture. After 
removing the unbound species by centrifugation and resuspension in water, a 1.0 µL 
aliquot the lipid capped AuNRs containing the captured lipopeptide was spotted onto a 
stainless steel MALDI plate and dried under vacuum. This process was repeated until 5.0 
µL of solution was deposited on the sample plate and then 1.0 µL of 1.0 mg/mL solution 
of α-Cyano-4-hydroxycinnamic acid (CHCA) was spotted over the dried sample spot.  
The sample was then analyzed by MALDI-MS (Figure 23). MALDI-MS analysis of the 
solution following the selective capture and concentration of the lipopeptide by the lipid 
capped AuNRs reveals a drastic improvement in our ability to detect the lipopeptide. 
The dominant signal in the spectra for the capture experiment corresponds to the 
lipopeptide [M+H]+ ion at m/z = 883.6.  In fact, the s/n ratio of the lipopeptide [M+H]+ 
peak has increased to ~550 and it is now the most abundant signal. The spectra labeled 
with numbers represent unidentified species present the serum.  
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Figure 23. MALDI mass spectrum of the lipopeptide lipid capped AuNR complex after 
the lipopeptide was captured from an 11 nM solution of lipopeptide in 3.0 mg/mL fetal 
bovine serum solution. The peaks labeled with numbers correspond to unidentified 
species present in the calf serum.  
 
 
 
 As a control experiment, an identical sample preparation procedure was repeated 
for the lipopeptide/serum solution without the addition of lipid capped AuNRs (Figure 
24).  Here, the most abundant peaks in the spectra correspond to serum components 
(peaks labeled 4, 7, and 9). More importantly, the lipopeptide is barely discernable in the 
spectra (S/N < 3). 
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Figure 24. MALDI mass spectrum of 11 nM lipopeptide solution in 3.0 mg/mL fetal 
bovine serum. The peaks labeled with numbers correspond to unidentified species 
present in the serum.  
 
 
 
 To further verify that selective capture of the lipopeptide is occurring due to the 
presence of the lipid capping, the AuNRs, control experiments were performed in which 
non-lipophilic capping agents were employed (mPEG-thiol or 4-aminothiophenol).18 In 
order to eliminate any effect or possible interferences from components of the serum, 
these control experiments were carried out with aqueous lipopeptide solutions and were 
performed using an identical capture protocol and sample preparation parameters as with 
the lipid-capped AuNR. An additional control experiment utilizing CTAB capped AuNR 
was performed, however, as previously noted, the CTAB functionalized AuNR were 
unable to withstand multiple washing steps and no analyte signals were observed by 
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MALDI-MS due to AuNR aggregation. MALDI-MS spectrum of the capture 
experiments utilizing mPEG-thiol capped AuNR (Figure 25) or 4-aminothiophenol 
capped AuNRs (Figure 26) contained no discernable lipopeptide signal above the 
background. It is important to note that incubation is essential for analyte capture. For 
example, when the lipid-AuNR were mixed with the serum solution and analyzed 
immediately, there was no significant increase in the lipopeptide signal (Figure 27) in 
comparison to the capture experiment, which was allowed to incubate at room 
temperature for 20 minutes before analysis.    
 
 
 
Figure 25. MALDI mass spectrum of the attempted capture of the lipopeptide using 
mPEG-thiol capped AuNRs. The lipopeptide was present at a concentration of 11 nM in 
water; however, there is no discernable signal for the target analyte using mPEG-thiol 
capped AuNRs as the affinity platform. 
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Figure 26. MALDI mass spectrum of the attempted capture of the lipopeptide using 4-
aminothiophenol capped AuNRs. The lipopeptide was present at a concentration of 11 
nM in water; however, there is no discernable signal for the target analyte using 4-
aminothiophenol capped AuNRs.  
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Figure 27. MALDI mass spectrum of lipid capped AuNRs mixed with an 11 nM 
lipopeptide solution in fetal bovine serum and analyzed immediately. 
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Conclusions 
 
 The data presented here illustrate the utility and applicability of lipid capped 
AuNRs as label-free biosensor platforms for both optical and mass spectrometry based 
detection.  Previous studies addressed the importance of lipid bilayers for stabilization of 
AuNRs, and tethering of lipid bilayers to the surface of the AuNRs also provides an 
effective medium for the capture of lipophilic analytes from solution.77,130 The AmB and 
lipopeptide capture data clearly illustrate the utility of the lipid-AuNR biosensor for the 
selective capture, detection, and identification of lipophilic analytes. This work 
underscores the potential of lipid-capped AuNRs for biosensor applications; however, 
lipid-capped AuNR may provide avenues for developing powerful multiplexed label-free 
sensor platforms.  For example, tailoring the chemical and physical properties by 
altering the composition of the lipids or by attaching targeting molecules to the 
headgroups of the lipids would allow for additional degrees of selectivity to be 
incorporated into the biosensor platform.  Such approaches would significantly enhance 
the selectivity of the lipid-AuNR platform, thereby extending the capability of the 
biosensor to target different types of analytes. For example, it should be possible to 
develop a multiplexing system that incorporates an array of lipid capped AuNR 
biosensors, which would serve to simultaneously target a variety of analytes in solution. 
Mass spectrometry then becomes an essential component of the label-free detection of 
the multiple targeted analytes owing to the low specificity of optical detection methods. 
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CHAPTER IV 
A SOL-GEL DERIVED SILVER NANOPARTICLE EMBEDDED THIN FILM FOR 
MASS SPECTROMETRY-BASED BIOSENSING∗ 
 
Introduction 
 Owing to their biological significance, the rapid detection of peptides, proteins 
and lipids has become the basis for the development of numerous biosensing techniques 
over the past several years. Among these techniques, matrix assisted laser desorption 
ionization mass spectrometry (MALDI-MS) has been proven to be invaluable for the 
analysis of a number of high molecular weight compounds;1-3,6 however its utility for 
analysis of small molecules (<1000 m/z) such as steroids and lipids has been limited due 
to significant background noise from matrix clusters that congest the low mass region of 
the spectra.4,7 A number of matrix free platforms have since been developed to probe 
lower mass region analytes with considerable success. One such method, desorption 
ionization on porous silicon (DIOS), utilizes etched silicon wafers to fabricate a porous 
nanostructure that can be used for directly desorbing and ionizing analytes from the 
surface.11-13,64 While this method has been proven successful in both minimizing 
background noise and detecting several low molecular weight compounds including 
peptides and organic compounds, the technique has been generally limited to basic 
analytes.131 Additionally, the shelf life of the DIOS platform is relatively short, owing to 
                                                
∗ Reprinted with permission from Gamez, R. C., Castellana, E. T., Russell, D. H. A Sol-Gel-Derived 
Silver-Nanoparticle-Embedded Thin Film for Mass Spectrometry-Based Biosensing. Langmuir 2013, 29, 
6502-6507. Copyright 2013 American Chemical Society. 
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its susceptibility to surface oxidation which results in decreased performance and 
reproducibility.11,131 
 Alternatively, the sol-gel method has recently gained considerable attention as a 
simple means for producing effective MS platforms via incorporation of organic 
matrices and optically active metal nanoparticles (NPs) that serve as UV energy 
absorbers. Separate studies utilizing thin films impregnated with α-cyano-4-
hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic acid (DHB) were capable of 
detecting a number of small molecules and proteins, respectively.132,133 Several 
oligonucleotides were successfully analyzed by doping 3,4-diaminobenzoic acid 
(DABA) or 3,5-DABA into sol-gel solutions during the preparation of thin films - a 
method that also proved to be effective in reducing interference signals associated with 
alkali metal salts without desalting steps prior to analysis.134 Incorporation of TiO2 into 
the sol-gel allowed for the detection of surfactants, peptides and tryptic digest products; 
however, the addition of a proton source in the form of citrate buffer was necessary for 
useful MS data.135 
 There are distinct advantages of the sol-gel method for the synthesis of metal 
NPs compared to traditional chemical reduction methods. Namely, organo-metallic 
precursors such as metal salts are often miscible with the starting solution, and 
controlled homogenous doping is easily achieved. Moreover, since high annealing 
temperatures are oftentimes employed, low mass organic residuals that may potentially 
interfere in MS analysis are incinerated during the process, thereby eliminating 
additional clean up steps.53,54 Here, we describe the preparation and implementation of a 
 57 
 
porous AgNP-embedded thin film platform prepared using standard sol-gel chemistry to 
form an optically active LDI-MS biosensor platform. The AgNP/thin film serves as an 
alternative matrix-free MS platform for the sensitive detection of a number of low 
abundance sterols from lipid vesicles as well as several analytes in various chemical 
classes. The combination of optically active NP with the high concentration of pores on 
the film surface provides several advantages from an analytical standpoint including: (i) 
increased sample loading offered by the larger surface area of the system, (ii) minimized 
sample preparation, (iii) high tolerance to salts by elimination of chemical stabilizers, 
and (iv) an extended shelf life (>1 year). 
 
Materials and Methods 
 All peptides (Angiotensin I, Angiotensin II, Angiotensin III, [Val4] Angiotensin 
III, Bradykinin, Substance P, etc.) were purchased from American Peptide Co., Inc. 
(Sunnyvale, CA). 1-2,-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) 
were acquired from Avanti Polar Lipids (Alabaster, AL). Triglyceride standard mixture, 
tetraethyl orthosilicate (TEOS), 2-ethoxyethanol and silver nitrate were purchased from 
Sigma-Aldrich, Inc. (St. Louis, MO). All aqueous solutions were prepared using 18.2 
MΩ/cm2 water (Barnstead EasyPure II, Thermo Scientific, Dubuque, IA). Boro-
aluminosilicate glass wafers, (25.4 x 25.4 mm; 0.5 mm thick) were purchased from 
Precision Glass & Optics. (Santa Ana, CA.) Glass wafers were cleaned by immersion in 
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a piranha solution (75% concentrated sulfuric acid, 25% concentrated hydrogen 
peroxide. Note: piranha solution is a vigorous oxidant and should be used with extreme 
caution) at 100°C for 30 minutes. Next, the wafers were rinsed thoroughly with water 
and baked at 150°C for 2 hours prior to use.  
 Porous AgNP impregnated thin films were prepared by the sol-gel method. First, 
15.9 mL of TEOS, 15.3 mL of 2-ethoxyethanol and 4.8 mL of distilled water were 
mixed at room temperature with stirring. Next, 0.5 mL of 0.5M nitric acid was added to 
the mixture to make the pH of the solution acidic. This solution was stirred at room 
temperature for 4 hours, then 1.46 g of silver nitrate was added and the mixture was 
allowed to stir for an additional 2 hours. After stirring, the clean glass wafers were 
coated with the silver-containing sol-gel solution by a spin coating process. Individual 
glass slides were placed on the spin coating platform, and the surfaces were subjected to 
4 mL of silver-containing sol-gel solution while spinning at 1200 RPM, for 30 seconds. 
The freshly coated wafers were then thermally treated in a furnace, in air. The furnace 
was ramped from room temperature to 700°C over 7 hours, then held at 700°C for 
3hours, and then followed by a ramp down to room temperature over 7 hours. The 
thermally treated films were stored under atmospheric conditions and used without 
further treatment.   
 Mass spectrometry data were acquired with a Voyager DE-STR MALDI-TOF-
MS (Applied Biosystems, Foster City, CA). UV-LDI-MS (337 nm) was obtained using a 
nitrogen laser (model VSL-337ND-S, Thermo Laser Science, Franklin, MA).  
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UV-vis absorption spectra of the thin films were acquired with an Agilent 8453 
spectrophotometer. SEM images were acquired with a FEI Quanta 600 FE-SEM and 
pore size distributions were determined directly from the SEM images using ImageJ 
particle size analysis software. X-ray Photoelectron Spectroscopy (XPS) measurements 
were carried out using Kratos Axis Ultra Imaging X-ray photoelectron spectrometer. A 
monochromated Al Kα source of hν = 1486.6 eV was used to probe the thin films. 
Binding energies were corrected by C 1s as a reference energy (C 1s = 248.8 eV).136 
Narrow scans of the Ag 3d regions were collected at analyzer pass energy of 40 eV after 
5 scan repetitions with a measuring step of 0.1 eV and a dwell time of 450 ms. 
 Thin films were taped directly to the surface of a standard stainless steel MALDI 
plate with copper tape. Samples (1.0 µL) analyzed were spotted directly to the surface of 
the AgNP impregnated films. Data acquisition was performed on a Voyager DE-STR 
equipped with a nitrogen laser (337 nm) in reflected mode. Laser intensities were 
adjusted to optimize the signal-to-noise ratio and desorbed ions were extracted into the 
flight tube with 20 kV after a 200 ns delay. Laser energies used for signal production 
ranged from ~3.5 to 6.0 µJ/pulse and laser energy measurements were acquired using an 
Ophir Nova Power/Energy meter coupled to a PE-10 Ophir Pyroelectric head (Ophir 
Laser Measurement Group, North Logan, UT). Values were recorded every 200 shots 
from a total of 1000 laser shots and measurements were taken in increments of 50 
arbitrary units via the instrument control settings. 
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Results and Discussion 
 The utility of AgNP impregnated thin films as platform for mass spectrometry 
analysis is demonstrated for a number of analytes which were individually spotted 
directly onto the surface and vacuum dried. LDI-MS analysis was performed by 
irradiation of each sample spot with 337 nm photons. It should be emphasized that LDI 
was carried out without the addition of organic matrices. We hypothesize that the 
overlap of the SPR band of the AgNP is capable of absorbing the incoming laser 
radiation which results in i) a rapid rise in temperature of the nanoparticles,36 which 
facilitates thermal desorption of the analyte, and ii) production of silver ions87 that ionize 
the samples spotted at the surface. LDI yields primarily silver ion clusters and the 
analytes are typically observed as Ag+ adducts that have a characteristic isotopic pattern 
consisting of two dominant peaks with an approximate 1:1 intensity ratio separated by 2 
m/z units. Data in Figure 28 demonstrate capability for the thin films to produce signals 
when 2.5 picomoles of Angiotensin II, (DRVYIHPF) are spotted on the surface and 
analyzed. Here, the only signal observed corresponds to a silver adduct of the peptide, 
[Angiotensin II+Ag]+ (m/z = 1152.5). The inset of Figure 28 shows the unique isotope 
pattern of the silver adducted analyte. Moreover, the spectrum shows minimal 
background noise and high signal-to-noise ratio (s/n ~250). Similar results were 
observed for a number of analytes, and the results are summarized in Table 1.     
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Figure 28. Mass spectrum of 2.5 pmol Angiotensin II (m/z = 1152.5) spotted on AgNP 
thin film surface and analyzed by LDI-MS. Inset shows a zoom-in view of the resulting 
peak. 
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Table 1. Analytes observed by spotting on the surface of the films and their respective  
sequence, mass to charge ratio (m/z) and limits of detection. 
 
 
 
 The versatility of AgNP thin films as a mass spectrometry platform was 
evaluated by analyzing a mixture of triglycerides (TAGs; C8-C16), and 
phosphatidylcholines (DMPC, DPPC, and POPC). The analytes in the mixture contain 
saturated hydrocarbon chain moieties, except for POPC, which has a single site of 
unsaturation in one of the hydrocarbon chains. As previously mentioned, the thin film 
was left untreated after initial preparation and the mixture was spotted directly onto the 
surface, dried and analyzed. The resulting mass spectrum (Figure 29) contains [M+Ag]+ 
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signals for each of the TAGs and phospholipids in the mixture. Interestingly, POPC, the 
only olefin present in the mixture, produced the lowest ion abundance despite being 
spotted at equal concentration (~6 picomoles) as the other analytes. This observation is 
consistent with our previous investigation, in which we attributed the lower ionization 
efficiency of POPC to a weaker interaction between the silver ions and the double bond 
owing to the steric hindrance imposed on the silver ion by the freely rotating long 
hydrocarbon chains.32,137 Table 2 includes the amount of picomoles of each analyte 
spotted onto the surface of the biosensor and the corresponding counts produced for each 
analyte. Similar results were obtained for small unilamellar vesicles composed of 
different sterols and phosphatidylcholines with either one or two unsaturated tails. In 
these experiments, the vesicles prepared were composed of ~99.5 mol% POPC and ~0.5 
mol% of stigmasterol, lanosterol, β-sitosterin, or cholecalciferol. For each of the 
preparations containing the olefins, preferential ionization of the sterols is observed, and 
the dominant peak in each of the resulting spectra corresponds to the Ag+ adduct of the 
sterol. Figure 30 contains a typical spectrum for the analysis of the sterol/unsaturated 
lipid vesicle mixture. For this analysis, the vesicles were diluted such that ~2 picomoles 
of stigmasterol and ~330 picomoles of POPC are spotted onto the surface. Despite the 
lower concentration of sterols compared to the phospholipids, the dominant signal 
corresponds to each of the individual sterols for the respective analyses. It should be 
noted that the sterols were also preferentially ionized from preparations using DOPC 
lipid vesicles (Figure 31). 
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Figure 29. Mass spectrum of a solution containing a mixture of triglycerides and three 
phosphatidylcholines (DMPC, DPPC, and POPC) analyzed by LDI-MS.  
 
 
 
 
 
Table 2. The table lists the amount in picomoles of each triglyceride and 
phosphatidylcholine spotted on the surface and the corresponding counts produced for 
each analyte. 
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Figure 30. Mass spectrum of vesicles composed of 99.5 mol % POPC and 0.5 mol % 
stigmasterol. The vesicles were diluted so that ~2 pmol of stigmasterol and ~330 pmol of 
POPC were spotted onto the surface. The POPC fragment corresponds to the loss of the 
phosphatidylcholine headgroup. 
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Figure 31. Mass spectrum of vesicles composed of ~83 mol % DOPC and ~17 mol % β-
sitosterin. The vesicles were diluted so that ~ 9 pmol of β-sitosterin and ~46 pmol of 
DOPC were spotted onto the surface. The DOPC fragment corresponds to the loss of the 
phosphatidylcholine headgroup. 
 
 
 
 Minimizing sample handling that might lead to sample loss is essential for 
successful detection of target molecules in the analysis of complex mixtures. This is 
especially true in the case of biological fluids that require clean up steps to reduce the 
high salt concentrations that frequently complicate mass spectrometry analysis owing to 
formation of salt adducts or production of chemical background noise. Figure 32 
contains mass spectra produced when three analytes were diluted to their final 
concentrations in 1.0 mM sodium chloride and analyzed using the AgNP thin films. 
Although the analytes are present at concentrations of ~10 pmol in high salt conditions, 
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the dominant signal in each of the individual spectra corresponds to [M+Ag]+ rather than 
[M+Na]+ for the respective analytes with little to no background noise or interference 
peaks. The concentrations for each of the analytes and the corresponding counts at those 
concentrations are summarized in the figure. Similar results were observed for a number 
of other biological buffers including 1.0 mM urea (Figure 33), 1.0 mM ammonium 
acetate (Figure 34), and tris-buffered saline (1.0 mM tris/3.0 mM NaCl) (Figure 35). 
Additionally, these results were acquired from the surface of a platform which had been 
prepared 16 months prior to the analysis (platform prepared December 2011; data taken 
April 2013).  
 
 
 
Figure 32. Mass spectra of Angiotensin I, II, and III when diluted in 1.0 mM NaCl and 
analyzed by LDI-MS.  
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Figure 33. Mass spectra of Angiotensin I, II, and III when diluted in 1.0 mM urea and 
analyzed by LDI-MS, 16 months after initial preparation of the thin film. 
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Figure 34. Mass spectra of Angiotensin I, II, and III when diluted in 1.0 mM ammonium 
acetate and analyzed by LDI-MS, 16 months after initial preparation of the thin film.  
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Figure 35. Mass spectra of Angiotensin I, II, and III when diluted in 1.0 mM Tris; 3.0 
mM NaCl and analyzed by LDI-MS, 16 months after initial preparation of the thin film. 
The peaks in each of the individual traces labeled with an asterisk (*) corresponds to 
sodium adducts ([M+Na]+) of the peptide. 
 
 
 
 During the course of developing the technology, AgNP embedded sol-gels were 
stored at atmospheric conditions for periods >1 year. Lengthy storage periods did not 
compromise the functionality of the platform. For example, the feasibility of preparing 
the thin films for future use as a durable analysis platform is demonstrated by the low 
mass region of a mass spectrum (data taken December 2011) of an unspotted thin film 
prepared in September of 2010 (Figure 36). The film is still capable of producing an 
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abundance of silver ions, which can be used to ionize analytes spotted on the surface a 
year after initial preparation, despite remaining under atmospheric conditions. In fact, 
when several different analytes were spotted on the surface of an aged film, abundant 
signal for 5.0 pmol of Angiotensin I (Figure 37), 2.5 pmol of Angiotensin II (Figure 
38), and 2.5 pmol of Angiotensin III (Figure 39) spotted onto the surface could still be 
produced. It should be noted that the low mass region does contain additional 
unidentified interference peaks, however, the higher mass region where analyte signal is 
produced remains relatively unchanged and analyte identification is easily achieved.  
 
 
Figure 36. Spectrum of the low mass region of an AgNP impregnated thin film taken 15 
months after initial preparation. Minimal interference peaks result (asterisks), despite 
remaining under atmospheric conditions and no additional surface treatment or washing 
steps after initial preparation. 
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Figure 37. Spectrum of analyte region of 5.0 pmol Angiotensin I spotted onto a silver 
nanoparticle embedded thin film. Analysis was performed 16 months after initial 
preparation of the thin film. Inset is a zoom-in view of the [M+Ag]+ peak. 
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Figure 38. Spectrum of analyte region of ~2.5 pmol Angiotensin II spotted onto a silver 
nanoparticle embedded thin film. Analysis was performed 16 months after initial 
preparation of the thin film. Inset is a zoom-in view of the [M+Ag]+ peak. 
 
 74 
 
 
Figure 39. Spectrum of analyte region of ~2.5 pmol Angiotensin III spotted onto a silver 
nanoparticle embedded thin film. Analysis was performed 16 months after initial 
preparation of the thin film. Inset is a zoom-in view of the [M+Ag]+ peak. 
 
 
 
 Despite these results demonstrating the thin films as a suitable method for mass 
spectrometry based biosensing, experiments aimed at tailoring the surface chemistry of 
the platform to improve selectivity have also been investigated. Selectivity becomes 
especially important when analyzing complex mixtures, as unwanted analytes may 
complicate identification of a target analyte during analysis if an enrichment method is 
unable to selectively capture, or “pull down” a specific type of compound. Previously, 
we demonstrated the selectivity of gold nanorods by functionalizing their surface with a 
lipid coating for the capture of lipophilic and membrane active components from fetal 
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bovine serum. Here, we aimed to target hydrophobic analytes by treating the surface of 
the thin films with, Bis(tridecafluoro-1,1,2,2-tetrahydrooctyl)tetramethyldisiloxane, Bis-
F26, a fluorinated siloxane compound previously demonstrated by Woo, et al. to aid in 
the desorption of analytes from the surface of porous silicon wafers. If left untreated, the 
porous silver nanoparticle embedded thin films result in a hydrophilic surface, owing to 
the presence of silanol groups at the surface of the film; hence functionalization is 
necessary to make the surface considerably more hydrophobic in nature. A typical 
surface treatment using Bis-F26 of the thin films follows a modified version of a 
nanostructure-initiator mass spectrometry (NIMS) protocol 15. In this modified protocol, 
the thin films are first cleaned with a piranha solution for 30 minutes, and then rinsed 
with water, and dried in an oven at 150°C. After drying, 100 µL of Bis-F26 was applied 
to the surface of the film and allowed to soak for 30 minutes. Excess Bis-F26 was 
removed from the surface of the film with a stream of nitrogen and then put in the oven 
at 150°C to dry for 15 minutes. If the thin film was not completely dried, this process 
was repeated until the thin film was completely dry. This platform was then used for an 
on-plate enrichment of hydrophobic analytes from fetal bovine serum. In a typical 
enrichment experiment, a target analyte was diluted to its final concentration in 3.0 
mg/ml fetal bovine serum, and a 5.0 µL aliquot was spotted to the surface of the film, 
and allowed to sit at room temperature for 30 minutes. Afterwards, the sample spot area 
was rinsed several times with water to remove any species that were not interacting with 
the surface. The thin film was then taped directly to the surface of a standard stainless 
steel MALDI plate with copper tape and MALDI-MS was performed by spotting 1.0 µL 
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of 5.0 mg/mL CHCA over the sample area. Data acquisition was performed on an 
Applied Biosystems 4800 Plus MALDI TOF/TOF equipped with a frequency tripled 
Nd:Yag laser (355 nm). Laser intensities were adjusted to optimize the signal-to-noise 
ratio and desorbed ions were extracted into the flight tube with 20 kV after a 200 ns 
delay. To compare the efficacy of this platform to our previously developed method 
utilizing lipid coated gold nanorods, an identical experiment was performed in which the 
target analyte was the lipopeptide, Myristoyl-Lys-Arg-Thr-Leu-Arg (Myr-KRTLR). 
Utilizing the gold nanorod platform, the lowest limits of detection for lipopeptide after 
enrichment resulted from a 500 µL aliquot of an 11 nM solution in fetal bovine serum, 
which is equal to a total of 5.0 nanograms (~5.5 picomoles) of lipopeptide available for 
enrichment from the mixture. Figure 40 demonstrates the capability of the on-plate 
enrichment method using the treated silver thin films to enrich an identical amount (5.0 
nanograms) of lipopeptide from a 3.0 mg/mL fetal bovine serum solution. In Figure 40, 
there is abundant signal corresponding to the target analyte with little to no background 
signal from any interfering species. A similar experiment was performed in which a total 
of 500 picograms of lipopeptide in 3.0 mg/ml in fetal bovine serum were spotted to the 
surface of a treated thin film for enrichment. Figure 41 demonstrates the resulting 
MALDI mass spectrum from 500 picograms of lipopeptide using the on-plate 
enrichment method. Similarly, the primary signal corresponds to the target analyte with 
little to no background signal from any interfering species. MALDI analysis of the same 
amount of lipopeptide in 3.0 mg/ml fetal bovine serum failed to produce any discernable 
signal for the target analyte (Figure 42). Additionally, the use of an untreated thin film 
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failed to produce the same results as those films treated with Bis-F26, indicating that the 
platform alone is not sufficient enough to enrich the analyte (Figure 43).   
 
 
 
 
Figure 40. MALDI mass spectrum of 5.0 nanograms of lipopeptide frfom a 3.0 mg/ml 
fetal bovine serum solution after on-plate enrichment using Bis-F26 treated thin film.    
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Figure 41. MALDI mass spectrum of 500 picograms of lipopeptide from a 3.0 mg/ml 
fetal bovine serum solution after on-plate enrichment using Bis-F26 treated thin film.    
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Figure 42. MALDI mass spectrum of the mixture containing 5.0 nanograms of 
lipopeptide in 3.0 mg/ml fetal bovine serum without on-plate enrichment. The only 
discernable signal is an unidentified background peak and the target analyte is not 
present.  
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Figure 43. MALDI mass spectrum of a control experiment of attempted on-plate 
enrichment of 500 picograms of lipopeptide from 3.0 mg/ml fetal bovine serum 
performed on an untreated film. The presence of the porous film is not sufficient enough 
to pull the target analyte out of the complex mixture. 
 
 
 
 Several additional analytes containing hydrophobic amino acid residues were 
also successfully enriched using Bis-F26 treated thin films. Indolicidin, 
(ILPWKWPWWPWRR) a cationic antimicrobial peptide and Neuropeptide Y Fragment 
(3-36) (SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY) are two such examples. 
Figures 44 and 45 demonstrate the successful enrichment of 5.0 nanograms of 
Indolicidin and Neuropeptide Y Fragment (3-36) in 3.0 mg/ml fetal bovine serum, 
respectively. In each of the individual spectra, the dominant signal corresponds to 
[M+H]+ for the target analyte and little to no background noise is observed.  
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 These results demonstrate the flexibility offered by surface treatment as a method 
to incorporate a level of specificity for on-plate capture of low abundance analytes from 
complex mixtures using the sol-gel derived thin films when combined with traditional 
MALDI-MS. Although the results presented here are relatively preliminary, they 
demonstrate an improvement on the detection limit of low abundance analytes in a 
complex mixture, such as fetal bovine serum in comparison to our previously established 
method using lipid coated gold nanorods. 
 
 
Figure 44. MALDI mass spectrum of 5.0 nanograms of Indolicidin from a 3.0 mg/ml 
fetal bovine serum solution after on-plate enrichment using a Bis-F26 treated thin film. 
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Figure 45. MALDI mass spectrum of 5.0 nanograms of Neuropeptide Y Fragment (3-36) 
from a 3.0 mg/ml fetal bovine serum solution after on-plate enrichment using a Bis-F26 
treated thin film. 
 
 
 
 After thermal treatment at 700°C, the resulting AgNP thin film has a distinct 
yellow color (Figure 46) which remains unchanged for a period of several months 
despite being stored under atmospheric conditions. The optical absorption spectrum of 
the silver doped thin film displays a strong absorption band centered at ~390 nm that is 
attributed to the surface plasmon resonance (SPR) of the AgNP in the film.34 Optical 
absorption of several regions of the films showed minimum variability in the optical 
properties across the platform (Figure 47). As evident from an overlay of the optical 
spectra of fresh and aged films shown in Figure 48, long storage periods under ambient 
 83 
 
conditions did not appear to significantly alter the optical properties of the film. The 
surface morphology of the thin films was examined by scanning electron microscopy 
(SEM), revealed the porous nature of the film (1400x magnification) (Figure 49) and the 
presence of AgNP at the surface (20,000x magnification) (Figure 50). A The average 
pore size distribution was determined to be ~650 nm in diameter which remained 
consistent across individual thin film preparations (Figure 51). 
 
 
 
Figure 46. Resulting thin film after spin coating and thermal treatment.  
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Figure 47. UV-vis of several different regions of a typical thin film prepared by 
thermally treating at 700°C. The strong surface plasmon band at around 400 nm remains 
constant across different regions of the film.  
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Figure 48. Optical absorption spectra of a (black) fresh and an (red) aged (>1 year) 
AgNP thin film. Note: the spectrum of the aged film is offset by 0.2 Abs for clarity. 
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Figure 49. SEM image of thin film surface at 1400x magnification revealing the porous 
nature of the surface of the thin film. 
 
 
 
 
Figure 50. SEM image of thin film surface at 20,000x  magnification. The bright spots in 
the image are AgNPs. 
 87 
 
 
Figure 51. Histogram of the pore sizes for a typical preparation of the AgNP embedded 
thin film. Average pore size was found to be 656±65.8nm across several individual 
preparations. 
 
 
 
 Although the mechanism governing the formation of the AgNPs is not yet 
entirely understood, there have been several investigations focused on the production 
and characterization of Ag-doped films utilizing the sol-gel method.52,55,56,138 In these 
studies it was discovered that reduction of the Ag+ is only achieved at temperatures 
above 500°C and that lower annealing temperatures do not yield nanoparticles. Epifani 
et al. suggested that reduction of the Ag+ to Ag0 is inhibited by the formation of silver 
complexes and reduction can only be achieved by thermal decomposition of the 
 88 
 
complexes. This conclusion was supported by the fact that heating at lower temperatures 
(300°C) produced no detectable optical absorption corresponding to the SPR band for 
AgNPs; a similar result was obtained when lower heating temperatures were used in our 
method of preparation (Figure 52). Previously, Weaver and Hoflund studied the thermal 
decomposition of Ag2O by X-ray photoelectron spectroscopy (XPS) and discovered 
annealing at a temperature of 490°C for 60 minutes was sufficient to reduce the bulk of 
the Ag2O sample to Ag metal.139 In our experiments, the formation of AgNP is further 
supported by XPS measurements of the films. Ag metal, AgO and Ag2O powder have 
been studied extensively by XPS and it has been established that an increase in the 
oxidation state of silver results in a negative shift of the binding energy of Ag 3d 
peaks.139-142 Figure 53 shows the Ag 3d core-level spectrum of the Ag thin film which 
exhibits an expected Ag 3d doublet. The peak at a binding energy of 368.2 eV is 
consistent with the previous assignment of the binding energy for the Ag 3d5/2 peak from 
Ag0at 368.1± 0.1eV.143 It should be noted that the best signal for the XPS experiments 
was obtained when the surface of the film was scratched just prior to analysis, leading us 
to hypothesize that AgNPs are not only at the surface of the film but embedded within 
the SiO2 matrix as well.  
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Figure 52. UV-vis of thin film prepared by thermally treating at 300°C (black) and 
700°C (red). The absence of the strong surface plasmon band at around 400 nm for the 
slides treated at 300°C suggests the lack of metallic silver nanoparticles. 
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Figure 53. The Ag 3d binding energy XPS spectrum of an AgNP embedded thin film. 
The resulting peaks indicate that silver exists in the elemental form. 
 
 
 
 In our method, the thin films were heated to a final temperature of 700°C to 
ensure the formation of AgNP and the decomposition of residual organics that can 
complicate the spectra during mass spectrometric analysis. The fact that there are few 
low mass interference peaks when the surface is interrogated by LDI-MS manifests the 
decomposition of organics. Additionally, the higher temperature also allows for the 
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freshly prepared AgNP films to be used without any additional handling steps such as 
washing or surface treatment after initial preparation. 
 
Conclusions 
 A porous AgNP impregnated thin film prepared by a sol-gel method is 
demonstrated as a flexible platform for LDI-MS of analytes of various chemical classes. 
The AgNP impregnated thin film absorbs incoming photons, resulting in desorption and 
ionization of analytes, which are observed as Ag+ adducts. This investigation focuses on 
the analysis of several non-olefin analytes, specifically peptides and several 
phospholipids/triglycerides with fully saturated hydrocarbon tails. Possibly of greater 
interest is the preferential ionization of sterols from vesicles composed primarily of 
olefinic phosphosphatidylcholines, which offers the possibility of a simplified approach 
for sterol analysis from mixtures. Moreover, the platform displayed an excellent shelf 
life and retained optical properties for over a year without compromising LDI-MS 
function - an appealing quality from a diagnostic standpoint where minimal sample 
preparation is often required for rapid analysis.  
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CHAPTER IV 
SUMMARY AND CONCLUSIONS  
 
 The use of nanomaterials for sensing applications has developed significantly 
over the past several years owing to the unique optical properties, and the ease of 
preparation. In this dissertation, we describe the utilization of the longitudinal surface 
plasmon resonance exhibited by gold nanorods (AuNRs) coupled with surface 
functionalization to promote laser desorption ionization and mass spectrometric 
detection of peptides utilizing near-IR wavelength laser pulses. In this investigation, it 
was also discovered that the hydrophobic nature of the surfactant used for the 
preparation of the AuNRs could be utilized to enrich low abundance hydrophobic 
analytes from aqueous solutions. These analytes were concentrated by the AuNRs and 
subsequently detected using the near-IR laser desorption ionization method previously 
discussed.  
 Similarly, an alternative method to stabilize and protect the AuNRs using 
phospholipids was developed and optimized to enrich not only hydrophobic, but 
membrane active components from aqueous and complex mixtures. By exploiting the 
unique optical properties of AuNRs, the successful analyte capture of a membrane active 
analyte from an aqueous solution by the phospholipid coated AuNRs was also 
demonstrated. Following the optical detection method, MALDI-MS was further used 
confirm the presence of the target analytes, whereas before enrichment, they were either 
previously undetectable or barely discernable against background noise in the spectra. 
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To further emphasize the utility of the phospholipid coated AuNRs as a versatile 
platform to enrich and pull down target analytes, it was demonstrated that they were 
capable of enriching an analyte in low abundance from a complex mixture, fetal bovine 
serum. Additionally, the AuNRs were capable of withstanding several centrifugation 
cycles, which was necessary for the removal of excess, unwanted or unbound species 
which could possibly interfere and complicate the analysis. Most importantly among 
these experiments, was the clear presence of the target analyte in each of the resulting 
spectra along with baseline resolution and excellent signal to noise, with few 
interference peaks.  
 The development and characterization of a silver nanoparticle based biosensor is 
also described. Using a silica based sol-gel method, a porous thin film with silver 
nanoparticles embedded within the structure was able to be produced. This thin film 
proved to be successful as a matrix-free platform for laser desorption ionization of a 
number of peptides, triglycerides, and lipids. Additionally, the platform displayed an 
excellent shelf-life, retaining its ability to produce signal for analytes spotted to the 
surface despite being left under atmospheric conditions for over one year. Preferential 
ionization of low abundance sterols from vesicles composed primarily of olefinic 
phospholipids was also observed, offering the possibility of a simplified approach for 
sterol analysis from complex mixtures.  
 Overall, the data presented in this dissertation has provided examples of the 
efficacy of nanomaterials of different shapes and composition to be utilized as mass 
spectrometry based biosensors. Several avenues exist for future work involving 
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phospholipid coated AuNRs. One such example, which was briefly investigated, 
however, not entirely optimized was the possibility of incorporating different lipids with 
functional headgroups for capture and pull down of specific side chains on peptides or 
proteins. Following a similar exchange protocol as outlined in Chapter III, one should be 
able to prepare phospholipid coated AuNRs and exchange the surface coating by 
incubating the AuNRs with vesicles composed primarily of the functional lipid 
headgroup of interest. In fact, preliminary experiments performed using this approach 
suggests that lipid exchange at the surface of the AuNRs is indeed possible by this 
method. Following derivatization, the functional AuNRs can be incubated with a mixture 
or solution under optimum reaction conditions containing a target analyte to produce a 
complex which can be pulled out of the solution and analyzed. Additionally, by 
producing and combining different types of functional AuNRs, a multiplex approach for 
enrichment and pull down of various kinds of analytes from a mixture is also possible.  
 The flexibility of the sol-gel method for production of thin films with different 
structural properties also presents an opportunity for future investigations. As noted in 
the discussion focusing on sol-gel chemistry in Chapter I, by simply changing the ratios 
of starting materials or the type of catalyst used, one can greatly influence the outcome 
of the final three dimensional structure of the silica network. Additionally, since most 
metal precursor salts are miscible with the starting solution, alternative metals can be 
doped into the solution to develop films containing different metal nanoparticles. 
Preliminary findings to produce similar silver nanoparticle embedded thin films have 
found that the production of film with smaller pore size (~100 nm diameter) is possible 
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by simply doping a surfactant, Tween-20, into the reaction mixture after an allotted time 
while maintaining other reaction conditions. The use of a thin film with smaller pore size 
is intriguing from a sample loading perspective, since for a given area, a higher density 
of pores would result in an increase in surface area and sample loading. A comparative 
study investigating the influence on the amount of signal produced for a given amount of 
analyte for smaller pore size versus larger pore size thin films could be undertaken. 
Alternatively, the treatment of the thin films with hydrophobic coatings for an on-plate 
enrichment method was briefly mentioned in Chapter IV. Using these surface coatings, 
and coupling with MALDI-MS, a method for selective enrichment of hydrophobic 
analytes from complex mixtures was demonstrated. Other surface modifications could 
feature a silane chemistry approach, which would give the possibility of decorating the 
surface of the thin films with functional groups that target side chains of peptides and 
proteins for added selectivity. 
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